Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non–Small Cell Lung Cancer: The Mayo Clinic Experience

C. Hobbs(Mayo Clinic in Florida), Robert C. Miller(Mayo Clinic), Michael G. Heckman(Mayo Clinic in Florida), William G. Rule(Mayo Clinic in Arizona), Nancy N. Diehl(Mayo Clinic in Florida), Stephen Ko(Mayo Clinic in Florida), Christopher L. Hallemeier(Mayo Clinic in Arizona), Steven E. Schild(Mayo Clinic Hospital), Sean S. Park(Mayo Clinic), Johnny R. Bowers(Mayo Clinic Hospital), Yolanda I. Garces(Mayo Clinic), Jonathan B. Ashman(Mayo Clinic in Arizona), Kenneth R. Olivier(Mayo Clinic), Sujay A. Vora(Mayo Clinic Hospital), Nitesh N. Paryani(Mayo Clinic in Florida), Joseph Accurso(Jacksonville College)
Mayo Clinic Proceedings Innovations Quality & Outcomes
December 26, 2017
Cited by 29


Related Papers

Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
|Journal of the National Comprehensive Cancer Network|2021|1k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
|Journal of the National Comprehensive Cancer Network|2019|1k
NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023
|Journal of the National Comprehensive Cancer Network|2023|480